At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
nonsurgical periodontal treatmentprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Investigating the Role of ABO Blood Group in the Response to the Nonsurgical Periodontal Treatment.
In Brief
An observational study evaluating nonsurgical periodontal treatment for Chronic Periodontitis. Completed, enrolled 60 participants across 1 site.
Detailed Summary
The aim of this study is to find out if one blood group phenotype is more responsive than the others to the nonsurgical periodontal treatment.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Periodontitis
CountriesSyria
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartJan 2018
First PostedAug 2018
Primary CompletionOct 2018
Study CompletionMar 2019
TodayJul 2026
First PostedAug 23, 2018
Enrollment StartJan 15, 2018
Primary CompletionOct 1, 2018
Study CompletionMar 10, 2019
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 7.9 years ago
Interventions
nonsurgical periodontal treatmentprocedure
patients will undergo nonsurgical periodontal treatment to reduce the relative attachment level and improve the probing depth. An initial session will be conducted to remove supra gingival plaque and calculus. another appointment is set to perform full moth scalling and root planing.